Chinook Therapeutics Inc Cvr (ADRO)

Stock-Based Compensation

$1.63M

Quarterly · Period ending: · USD

ADRO logo

ADRO Stock-Based Compensation

Latest reported$1.63M
ADRO Quarterly Stock-Based Comp ($109.00K → $1.63M)
High-resolution chart · PNG

ADRO stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Chinook Therapeutics Inc Cvr Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
1,632,000
3,028,000
2,035,000
2,325,000
3,075,000
3,336,000
3,703,000
4,002,000
4,221,000
4,327,000
4,924,000
4,366,000
4,025,000
3,997,000
3,988,000
4,154,000
3,784,000
3,325,000
3,743,000
3,198,000
1,887,000
2,765,000
580,000
202,000
164,000
95,000
109,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.